Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5683)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 24, 2021 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Peravali M, Gomes-Lima C, Tefera E, Baker M, Sherchan M, Farid S, Burman K, Constantinescu F, Veytsman I. Racial disparities in immune-related adverse events of immune checkpoint inhibitors and association with survival based on clinical and biochemical responses. World J Clin Oncol 2021; 12(2): 103-114 [PMID: 33680877 DOI: 10.5306/wjco.v12.i2.103] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v12/i2/103.htm |
| Number | Citing Articles |
| 1 |
Annie Chang, Raja M Flores, Emanuela Taioli. Unequal racial distribution of immunotherapy for late-stage non–small cell lung cancer. JNCI: Journal of the National Cancer Institute 2023; 115(10): 1224 doi: 10.1093/jnci/djad132
|
| 2 |
Akhil Rekulapelli, Lucas E. Flausino, Gayatri Iyer, Rajesh Balkrishnan. Effectiveness of immunological agents in non‐small cell lung cancer. Cancer Reports 2023; 6(1) doi: 10.1002/cnr2.1739
|
| 3 |
Jeffrey Shi Kai Chan, Pias Tang, Teddy Tai Loy Lee, Oscar Hou In Chou, Yan Hiu Athena Lee, Guoliang Li, Fung Ping Leung, Wing Tak Wong, Tong Liu, Gary Tse. Association between immune checkpoint inhibitors and myocardial infarction in Asians: A population‐based self‐controlled case series. Cancer Medicine 2023; 12(8): 9541 doi: 10.1002/cam4.5729
|
| 4 |
Raymond U. Osarogiagbon, Helmneh M. Sineshaw, Joseph M. Unger, Ana Acuña-Villaorduña, Sanjay Goel. Immune-Based Cancer Treatment: Addressing Disparities in Access and Outcomes. American Society of Clinical Oncology Educational Book 2021; (41): 66 doi: 10.1200/EDBK_323523
|
| 5 |
Vidya Sankar Viswanathan, Amit Gupta, Anant Madabhushi. Novel Imaging Biomarkers to Assess Oncologic Treatment–Related Changes. American Society of Clinical Oncology Educational Book 2022; (42): 687 doi: 10.1200/EDBK_350931
|
| 6 |
Jeffrey Shi Kai Chan, Ishan Lakhani, Teddy Tai Loy Lee, Oscar Hou In Chou, Yan Hiu Athena Lee, Yiu Ming Cheung, Hoi Wa Yeung, Pias Tang, Kenrick Ng, Edward Christopher Dee, Tong Liu, Wing Tak Wong, Gary Tse, Fung Ping Leung. Cardiovascular Outcomes and Hospitalizations in Asian Patients Receiving Immune Checkpoint Inhibitors: A Population-based Study. Current Problems in Cardiology 2023; 48(1): 101380 doi: 10.1016/j.cpcardiol.2022.101380
|
| 7 |
Tsutomu Anraku, Hideki Hashidate, Tomoyuki Imai, Yoshiaki Kawakami. Successful treatment of immune‐related cystitis with bladder hydrodistension. IJU Case Reports 2023; 6(4): 211 doi: 10.1002/iju5.12588
|
| 8 |
Astha Thakkar, Michelly Abreu, Kith Pradhan, R. Alejandro Sica, Aditi Shastri, Noah Kornblum, Nishi Shah, Ioannis Mantzaris, Kira Gritsman, Eric Feldman, Richard Elkind, Susan Green-Lorenzen, Amit Verma, Ira Braunschweig, Mendel Goldfinger. Efficacy and safety of CAR-T cell therapy in minorities. Bone Marrow Transplantation 2022; 57(7): 1187 doi: 10.1038/s41409-022-01670-1
|
| 9 |
Gianluca Nazzaro, Stefano Buffon, Serena Giacalone, Carlo Alberto Maronese, Angelo Valerio Marzano. Skin manifestations associated with checkpoint inhibitors. JEADV Clinical Practice 2022; 1(2): 73 doi: 10.1002/jvc2.27
|
| 10 |
Avital Klein-Brill, Shlomit Amar-Farkash, Keren Rosenberg-Katz, Ronen Brenner, Jürgen C. Becker, Dvir Aran. Comparative efficacy of combined CTLA-4 and PD-1 blockade vs. PD-1 monotherapy in metastatic melanoma: a real-world study. BJC Reports 2024; 2(1) doi: 10.1038/s44276-024-00041-1
|